Drugs / MediReg®
last change Dec 2025 re-read 3 minutes ago

MediReg®

Developed for
azoospermia · oligospermia · spermatogenic failure
Investigated by
Lomonosov Moscow State University Medical Research and Educational Center

Trials 1

PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1/2 NCT06869863 Nov 2024 → Dec 2025 overdue azoospermia, oligospermia, spermatogenic failure Lomonosov Moscow State University Medical Research and Educational Center Recruiting No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as MediReg ClinicalTrials.gov intervention name — accepted as the source's own label NCT06869863 ↗
Route Other “The drug is injected once under the protein sheath of both testicles.” NCT06869863 ↗